FDA Safety and Innovation Act, Part 1
Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They… read more
Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and Innovation Act. They told committee members that the overall process was going well despite some fiscal difficulties caused by sequestration and other budget cuts. The bill gave the FDA various new powers, including faster generic prescription drug approval, improving the review process for medical devices, and better safety standards for imported drugs. close
People in this video
-
-
-
-
Jeffrey E. Shuren M.D. Director U.S. Food and Drug Administration->Center for Devices and Radiological Health
-
-
- Ed Whitfield U.S. Representative [R] Kentucky
-
Janet Woodcock M.D. Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
Hosting Organization
More Videos From
FDA Provides Update on New Public Health Safeguards
Related Video
-
FDA Safety and Innovation Act, Part 2
Senior Food and Drug Administration (FDA) officials gave an update on the implementation of the 2012 FDA Safety and…
-
FDA Oversight
Anna Edney talked about the responsibilities of the Food and Drug Administration (FDA) and the role of Congressional…
-
FDA Enforcement Policies
The committee heard testimony from persons in the Food and Drug Administration on the performance of the FDA in…
-
The Future of the Food and Drug Administration
The acting Commissioner addressed an FDA Science Forum celebrating the agency’s 100th anniversary. His topic was, “Creating…